Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:11 AM
Ignite Modification Date:
2025-12-25 @ 1:11 AM
NCT ID:
NCT04288193
Eligibility Criteria:
Inclusion Criteria:
* Participant enrolled in a PACE organization during the implementation time period;
* PACE organization contractually receiving pharmacy services from CareKinesis during the implementation time period; and,
* Participant's prescriber determines that the participant could potentially benefit from deprescribing the antipsychotic.
Exclusion Criteria:
* A diagnosis of bipolar disorder, schizophrenia, schizo-affective disorder, acute delirium, Tourette's syndrome, tic disorders, autism, intellectual disability, developmental delay, obsessive-compulsive disorder, alcoholism, cocaine abuse, Parkinson's disease psychosis, or major depressive disorder for which the antipsychotic is specifically prescribed as adjunctive treatment;
* Participant's prescriber determines that the participant would likely not benefit or could be harmed from deprescribing the antipsychotic; and,
* Participant, or healthcare decision-maker on behalf of the participant (e.g., caregiver) refuses to participate in the deprescribing initiative.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
55 Years
Study:
NCT04288193
Study Brief:
Protocol Section:
NCT04288193